Advanced Aseptic Technology Provides Glass-Free Delivery of Injectable Drugs
Catalent's Advasept platform uses blow-fill-seal technology to aseptically manufacture, fill, and seal a polymeric primary container for injectable drugs.
Catalent Pharma Solutions launched its Advasept technology for the advanced aseptic filling of injectable drugs. The new platform provides a glass-free, aseptically filled, primary container that reduces or eliminates many concerns associated with traditional glass vials, including the potential for glass particulate contamination and the risk of accidental breakage in transit or use. Catalent uses blow-fill-seal manufacturing technology to aseptically manufacture, fill, and seal a polymeric primary container. Advasept stoppered vials are currently produced in 10-mL, 50-mL and 100-mL sizes and are available with pop-off or twist-off tops. Containers can be tailored to meet the unique needs of customers across many markets, such as biologics, pharmaceuticals, generics, and animal health.
Source: Catalent
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
